We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First Insurance Coverage of NGS and Proteomic Diagnostic Platform

News   Jan 12, 2016

 
First Insurance Coverage of NGS and Proteomic Diagnostic Platform
 
 
Advertisement
 

RELATED ARTICLES

CRISPR-Based Malaria Testing on the Fly

News

A multi-disciplinary research collaboration created a field-applicable, ultrasensitive diagnostic assay that specifically detects DNA sequences from all Plasmodium species in symptomatic and asymptomatic malaria.

READ MORE

Well-Known Biomarker for Neurodegenerative Disease Detectable in the Eye

News

A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye.

READ MORE

Rapid Test for COVID-19 Shows Improved Sensitivity

News

A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard COVID-19 diagnostic.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE